Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 4,070 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard of Care control group Clear all

Conditions: Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant, GBM, Brain Cancer, Glioblastoma, IDH-wildtype, Glioblastoma Multiforme, Adult
Interventions: Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation, Temozolomide and Radiation Alone; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 432 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Best Practice, Exercise Counseling, Exercise Intervention, Magnetic Resonance Imaging, Neuropathy Assessment, Questionnaire Administration; Other · Procedure
Lead sponsor: University of Rochester NCORP Research Base; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 93
States / cities: Fresno, California • Martinez, California • Roseville, California + 70 more

Conditions: Acute Kidney Injury
Interventions: Conventional Foley Catheter(Medline), Accuryn Foley Catheter; Device
Lead sponsor: Dang Tan Phat; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Diabetes, Type 2 Diabetes (T2D)
Interventions: CareSmarts Mobile Health Diabetes Program, Standard of Care Reminders and Self Assessments; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Smoking &Amp; Tobacco Cessation
Interventions: Experimental Smoking Cessation Program, Control Smoking Cessation Program; Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1,647 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Diabetes, Diabetes Mellitus, Infected Wound, Infected Ulcer of Skin
Interventions: Phototherapy, Debridement Surgery and Wound Dressing; Device · Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Phantom Limb Pain, Phantom Pain, Phantom Sensation, Pseudomelia
Interventions: Sham (Comparator) Plasma Ball, Mirror; Device
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 30 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2019
U.S. locations: 1
States / cities: San Diego, California

Conditions: Telemedicine
Interventions: PRACTICE-DM, Standard VA Home Telehealth; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Durham, North Carolina • Richmond, Virginia

Conditions: Bleeding, Colorectal Disorders, Thromboembolism, Tranexamic Acid
Interventions: Tranexamic acid; Drug
Lead sponsor: Kristen Ban; Other
Eligibility: 18 Years to 100 Years
Enrollment: 394 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Type 1 Diabetes, Hypoglycemia, Hyperglycaemia Due to Type 1 Diabetes Mellitus, Menstruation Disturbances
Interventions: Personalized modifications to treatment to address menstrual cycle effects on glycemia; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Suicide Prevention
Interventions: SBIRT+12, SBIRT+Usual Care; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 34 Years
Enrollment: 698 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Articular Cartilage Disorder of Knee, Cartilage Damage, Microfractures
Interventions: microfracture surgery + HST003; Biological
Lead sponsor: Histogen; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 5
States / cities: Vail, Colorado • Bradenton, Florida • Bethesda, Maryland + 2 more

Conditions: Emergency Department, Health, Subjective, Health Care Utilization
Interventions: PATH Intervention; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acute Myeloid Leukemia
Interventions: none (observational study); Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Liver Transplant Rejection, Liver Transplant Failure and Rejection
Interventions: N/A-Observational Study; Other
Lead sponsor: St. Louis University; Other
Eligibility: 1 Year and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Maternal Dietary Diversity, Iron-Folic Acid Supplementation, Early Initiation of Breastfeeding
Interventions: Health Facility Level Interventions, Community Level Interventions, Health System Level Interventions; Behavioral
Lead sponsor: International Food Policy Research Institute; Other
Eligibility: 15 Years to 49 Years · Female only
Enrollment: 8,110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Chronic Lower Back Pain
Interventions: Osteopathic Manipulative Medicine, Phototherapy; Procedure
Lead sponsor: New York Institute of Technology; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2025
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Complication of Surgical Procedure, Postoperative Infection
Interventions: CALYPSO, Standard Care; Other · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Quality of Life, Injection Site Reaction, Adverse Drug Event, Systemic Reaction
Interventions: mRNA COVID-19, IIV4, Placebo (saline); Biological · Other
Lead sponsor: Duke University; Other
Eligibility: 5 Years and older
Enrollment: 348 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Baltimore, Maryland • Durham, North Carolina • Cincinnati, Ohio

Conditions: Substance Abuse, Substance Addiction, Substance Use Disorder (SUD), Substance Use (Drugs, Alcohol), Human Immunodeficiency Virus (HIV)
Interventions: The TLC Program; Behavioral
Lead sponsor: Illinois Institute of Technology; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Facetogenic Back Pain, Back Pain
Interventions: Allogeneic Human Mesenchymal Stem Cells (hMSCs), Placebo; Biological · Drug
Lead sponsor: Joshua M Hare; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Obstructive Sleep Apnea of Adult
Interventions: Atorvastatin 10mg, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Foot Fusion
Interventions: Augment® Bone Graft, Standard of Care; Device · Procedure
Lead sponsor: BioMimetic Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 414 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 31
States / cities: Tucson, Arizona • San Francisco, California • Santa Cruz, California + 27 more

Conditions: Venous Thromboembolism, Bleeding
Interventions: Pharmacogenetic-based warfarin dosing, Usual care warfarin dosing; Genetic · Other
Lead sponsor: Gwen McMillin; Other
Eligibility: 18 Years and older
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Salt Lake City, Utah

Search by objective public record fields.

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy

Intraabdominal Pressure Monitoring Urinary Catheter and Kidney Perfusion Pressure

NYULMC CareSmarts Pilot

An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Adjunctive Phototherapy Treatment of Infected Diabetic Ulcers

Perioperative Mirror Therapy and Phantom Limb Pain

Practical Telemedicine to Improve Control and Engagement for Veterans With Clinic-Refractory Diabetes Mellitus

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes

Suicide in Urban Natives: Detection and Networks to Combat Events

Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline Cartilage

Practical Alternative to Hospitalization

Chemotherapy-related Cognitive Impairment and Acute Leukemia

Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients

Assessing the Feasibility of Integrating a Package of Maternal Nutrition Interventions Into Antenatal Care Services in Burkina Faso

Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

The Trans-Led Care Study

Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain

Endothelial Function in Obstructive Sleep Apnea

Augment® Bone Graft (Formerly GEM OS™1 Bone Graft) Compared to Autologous Bone Graft in Foot and Ankle Fusions

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)